Infertility knows no boundaries. It’s estimated that 10% of the world’s childbearing population is struggling to get pregnant or stay pregnant. Whether you’re from Manhattan or Madrid, the dream of having a family sometimes needs a little help to be a reality. With the right team of global experts in the field, the safest and most innovative solutions, and commitment to success, you have reason to have hope.
We proudly announce the merger of IVI and RMANJ, two global experts leading the way in reproductive medicine research and care providing assisted reproduction and related services effective April 1, 2017.
“As one unified global entity, our commitment to offering evidence-based fertility solutions that offer the greatest chance of success in the shortest time necessary knows no boundaries – geographic or otherwise. Last year patients came to RMANJ from over 30 US states and 40 countries. Now together with IVI, we’re better positioned to enter new markets and help bring new hope to new patients,” added Dr. Richard T. Scott, Jr., a founding partner and laboratory director of RMANJ.
IVI-RMA Global and its affiliated practices employee nearly 2,400 people across 70 locations around the world, maintaining a team of over 200 physicians, and over 300 scientists and researchers. IVI-RMA Global and its board of directors, comprised of the founding partners of IVI and RMANJ, oversee several different international business units.
“I have known Dr. Scott for many years, and we admire and respect each other. I have always pursued the goal of introducing our company to the United States, and today I am pleased we have made it. The key to achieve this step was RMANJ. We share much of the same medical-scientific and business values and interests. This alliance will allow us to take full advantage of the expertise, experience and distinguishing elements of both companies for the benefit of our patients and employees,” offered Dr. Antonio Pellicer, President, IVI.
Dr. José Remohí a founding partner of IVI and member of the board of directors shared “being in the United States is a dream come true and RMA of New Jersey proved to be the best companion. They are commercial and scientific leaders in reproductive medicine in the United States. This union will allow us to enhance our field of investigation, the fundamental pillar of IVI since its inception which has enabled us to achieve high rates of success – a fact that our patients value when choosing our services.”
As the rest of 2017 unfolds, the newly merged organization will align teams and capabilities with a singular purpose: to provide hopeful patients from around the world with access to the global leaders in the field of reproductive medicine, the safest and most innovative solutions, and a commitment to success that’s measured in months and not years.